Recent Security Class Actions

Array Technologies Inc. Common Stock (NASDAQ: ARRY)

Company Name:Array Technologies Inc. Common Stock
Stock Symbol:NASDAQ: ARRY
Class Period Start:06/30/2016
Class Period End (inclusive):03/17/2017
Filing Deadline:01/22/2018

Array is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. The Company’s lead cancer drug binimetinib (MEK162) was evaluated in multiple trials and combinations, including a Phase 3 “NEMO” study versus dacarbazine in unresectable or metastatic NRAS-mutant melanoma patients.